Ruconest is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Pharming Healthcare Inc.. The primary component is Conestat Alfa.
Product ID | 71274-350_66ace473-b032-d108-e053-2991aa0a91d0 |
NDC | 71274-350 |
Product Type | Human Prescription Drug |
Proprietary Name | Ruconest |
Generic Name | C1 Esterase Inhibitor Recombinant |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-04-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125495 |
Labeler Name | Pharming Healthcare Inc. |
Substance Name | CONESTAT ALFA |
Active Ingredient Strength | 2100 U/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-04-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125495 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-04-01 |
Marketing Category | BLA |
Application Number | BLA125495 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-04-01 |
Ingredient | Strength |
---|---|
CONESTAT ALFA | 2100 U/1 |
SPL SET ID: | 66d3fecb-32a4-7781-e053-2a91aa0a83ca |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
68012-350 | Ruconest | c1 esterase inhibitor recombinant |
69913-350 | Ruconest | c1 esterase inhibitor recombinant |
70383-350 | Ruconest | c1 esterase inhibitor recombinant |
71274-350 | Ruconest | c1 esterase inhibitor recombinant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RUCONEST 85134646 4095324 Live/Registered |
Pharming Intellectual Property B.V. 2010-09-21 |